NCT00047606

Brief Summary

The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after six weeks of treatment in Caucasian and Japanese subjects.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Aug 2002

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2002

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 11, 2002

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2003

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2003

Completed
Last Updated

August 17, 2012

Status Verified

August 1, 2008

Enrollment Period

1.3 years

First QC Date

October 8, 2002

Last Update Submit

August 16, 2012

Conditions

Open-angle GlaucomaOcular Hypertension

Keywords

open-angleglaucomaocularhypertensionPOAGIrisPigmentationJapanese

Interventions

IOP Lowering MedicationsDRUG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Adults of Caucasian and Japanese Ethnicity

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular HypertensionGlaucomaHypertension

Condition Hierarchy (Ancestors)

Eye DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2002

First Posted

October 11, 2002

Study Start

August 1, 2002

Primary Completion

November 1, 2003

Study Completion

November 1, 2003

Last Updated

August 17, 2012

Record last verified: 2008-08